I'm an adult with a history of depression or anxiety, taking escitalopram (Lexapro), and I'm experiencing an annoying feeling in my urethra, could this be a side effect of the medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urethral Discomfort While Taking Escitalopram

Yes, escitalopram can cause urethral discomfort and urinary symptoms, though this is an uncommon side effect that warrants evaluation to rule out other causes before attributing it solely to the medication. 1

Evidence for Escitalopram-Related Urinary Symptoms

  • Escitalopram has been documented to cause acute urinary retention (AUR) in case reports, where normal micturition resumed only after discontinuing the medication without further need for catheterization 1
  • The urethral discomfort you're experiencing may represent a milder manifestation along the same spectrum of serotonergic effects on bladder and urethral function 1
  • SSRIs are not typically suspected as causes of urinary symptoms, which means this side effect is often overlooked due to limited reporting in the literature 1

Mechanism and Related Concerns

  • Escitalopram is the most selective SSRI with minimal anticholinergic activity (six times less potent than citalopram at muscarinic receptors), which makes direct anticholinergic urinary retention less likely but doesn't eliminate serotonergic effects on the genitourinary system 2, 3
  • Related SSRIs like citalopram have been associated with other genitourinary effects including priapism, suggesting serotonergic modulation of lower urinary tract function 4

Immediate Evaluation Steps

  • Rule out urinary tract infection, urethritis, or sexually transmitted infections with urinalysis, urine culture, and appropriate STI testing if sexually active 1
  • Assess for benign prostatic hyperplasia (BPH) if male or pelvic floor dysfunction if female, as these conditions can be unmasked or worsened by medications 4
  • Review all concomitant medications for anticholinergic properties (antihistamines, overactive bladder medications, antipsychotics) or alpha-blockers that could interact 1, 4
  • Verify adequate hydration status and rule out diabetes or other metabolic causes of urinary symptoms 1

Management Algorithm

If Medical Causes Are Ruled Out:

  1. Consider dose reduction of escitalopram from your current dose to the lowest effective dose (5-10 mg daily), as urinary symptoms may be dose-dependent 1

  2. If symptoms persist after dose reduction for 1-2 weeks, switch to an alternative SSRI with different pharmacologic properties:

    • Sertraline 50-200 mg daily has a lower risk of certain side effects and extensive safety data 5
    • Avoid paroxetine due to higher anticholinergic activity that could worsen urinary symptoms 5
  3. If switching SSRIs doesn't resolve symptoms, consider switching to a non-SSRI antidepressant:

    • Bupropion SR 150-300 mg daily has no serotonergic activity and minimal genitourinary effects 5
    • SNRIs (venlafaxine, duloxetine) are alternatives but may have their own urinary side effects 5

Critical Monitoring Points

  • Document the temporal relationship between escitalopram initiation/dose changes and symptom onset 1
  • Monitor for progression to urinary retention (inability to void, bladder distension, overflow incontinence) which would require immediate discontinuation 1
  • Allow 4-7 days after medication discontinuation to assess symptom resolution, as this was the timeframe in documented cases 1

Common Pitfalls to Avoid

  • Don't assume the symptom is unrelated to escitalopram simply because urinary effects are rarely reported with SSRIs 1
  • Don't add anticholinergic medications (like oxybutynin for overactive bladder) without first addressing the potential SSRI contribution, as this could worsen your depression/anxiety 6
  • Don't abruptly discontinue escitalopram without medical supervision due to discontinuation syndrome risk; taper over 1-2 weeks minimum 5

When to Seek Urgent Care

  • Inability to urinate for >6-8 hours 1
  • Severe suprapubic pain or bladder distension 1
  • Fever, flank pain, or hematuria suggesting infection or other acute pathology 1

References

Research

Escitalopram-associated acute urinary retention.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2013

Research

Citalopram-induced priapism.

Pharmacotherapy, 2002

Guideline

Tratamiento del Trastorno de Ansiedad Generalizada Resistente a Monoterapia con Escitalopram

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can we give escitalopram (citalopram's enantiomer) to patients with depression or anxiety disorders?
What is the comparison between sertraline (Zoloft) and escitalopram (Lexapro) for treating depression or anxiety disorders?
What medication management is recommended for a 15-year-old patient with depression, anxiety, frequent nightmares, social anxiety, and body dysmorphia, currently taking 10mg of escitalopram (citalopram) daily, with persistent symptoms and sleep issues?
What is the next medication to try for anxiety dominant mixed depression if Lexapro (Escitalopram) is causing excessive sleepiness?
What are the next steps for a 37-year-old female (YOF) with ongoing anxiety, low mood, and side effects of weight gain and insomnia while taking escitalopram (Lexapro) 10mg?
What is the best treatment approach for a patient with a history of dyspepsia, bloating, abdominal pain, diarrhea, and vomiting, currently taking Zepbound (Esomeprazole) and experiencing traveler's diarrhea?
What are the treatment options for a patient with a short PR interval, potentially indicating Wolff-Parkinson-White syndrome, and experiencing symptoms such as palpitations, shortness of breath, or chest pain?
Can a patient have Hereditary Hemorrhagic Telangiectasia (HHT) and Polycythemia Vera (PV) simultaneously?
What is the role of Intravenous Immunoglobulin (IVIG) in treating thrombocytopenia, particularly in patients with immune thrombocytopenia purpura (ITP)?
What are the treatment options for a patient with surgical scars and keloids, considering laser treatment?
What are the symptoms of pulmonary hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.